ID: ALA13204

Max Phase: Preclinical

Molecular Formula: C15H19NO2

Molecular Weight: 245.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)CC1(CCCCC1)[N+]([O-])=C2

Standard InChI:  InChI=1S/C15H19NO2/c1-18-14-6-5-12-11-16(17)15(10-13(12)9-14)7-3-2-4-8-15/h5-6,9,11H,2-4,7-8,10H2,1H3

Standard InChI Key:  OHGXCDCEUCQCQZ-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 245.32Molecular Weight (Monoisotopic): 245.1416AlogP: 2.88#Rotatable Bonds: 1
Polar Surface Area: 35.30Molecular Species: ACIDHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.16CX Basic pKa: CX LogP: 0.11CX LogD: 2.13
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.56Np Likeness Score: 0.48

References

1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA.  (1996)  Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides,  (10): [10.1016/0960-894X(96)00181-3]

Source